Nj State Employees Deferred Compensation Plan Sarepta Therapeutics, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 6,900 shares of SRPT stock, worth $144,486. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,900
Previous 6,900
-0.0%
Holding current value
$144,486
Previous $838,000
47.49%
% of portfolio
0.06%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$216 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$190 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$189 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$85.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$70.5 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.83B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...